KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Non Operating Investment Income (2016 - 2025)

Astrana Health's Non Operating Investment Income history spans 10 years, with the latest figure at -$807000.0 for Q3 2025.

  • For Q3 2025, Non Operating Investment Income fell 43.85% year-over-year to -$807000.0; the TTM value through Sep 2025 reached -$521000.0, down 130.49%, while the annual FY2024 figure was $731000.0, 115.96% up from the prior year.
  • Non Operating Investment Income for Q3 2025 was -$807000.0 at Astrana Health, down from $14000.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $50.2 million in Q4 2021 and bottomed at -$60.9 million in Q3 2021.
  • The 5-year median for Non Operating Investment Income is -$342000.0 (2023), against an average of -$2.2 million.
  • The largest annual shift saw Non Operating Investment Income soared 146.03% in 2023 before it crashed 114.32% in 2024.
  • A 5-year view of Non Operating Investment Income shows it stood at $50.2 million in 2021, then tumbled by 107.33% to -$3.7 million in 2022, then soared by 135.16% to $1.3 million in 2023, then plummeted by 75.58% to $316000.0 in 2024, then crashed by 355.38% to -$807000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Non Operating Investment Income are -$807000.0 (Q3 2025), $14000.0 (Q2 2025), and -$44000.0 (Q1 2025).